In a report released today, Oliver McCammon from LifeSci Capital maintained a Buy rating on Aura Biosciences Inc, with a price target of $23.00. Claim 55% Off TipRanks. Unlock hed ...
LifeSci Capital analyst Oliver McCammon maintained a Buy rating on Perspective Therapeutics today and set a price target of $15.00. McCammon covers the Healthcare sector, focusing on stocks such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results